KCT0008182招募中未知
A cohort study of the performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE pilot study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Patients who successfully received a drug-eluting stent after diagnosis of acute coronary syndrome
- •2. Patients who voluntarily participated in this study and gave written consent
排除标准
- •1. Age less than 19 years
- •2. Contraindications to prasugrel or ticagrelor: history of intracranial hemorrhage, active bleeding, etc.
- •3. Subjects whose life expectancy is less than 1 year
- •4. Subjects who are judged unsuitable by investigators
研究者
相似试验
已完成
3 期
Evaluation of the effectiveness of oral Aspirin in reducing complex regional pain syndrome (CRPS)Condition 1: Complex regional pain syndrome. Condition 2: distal radius fracture.Complex regional pain syndrome I (CRPS I)Fracture at wrist and hand levelIRCT20180116038391N1Iran University of Medical Sciences80
尚未招募
Unknown
Do we really need moderate to high dose aspirin in treatment of Kawasaki disease ?CTRI/2024/06/068247INSTITUTE OF CHILD HEALTH
尚未招募
2 期
The effect of Aspirin in preventing preeclampsiaPre-eclampsia.Pre-eclampsiaIRCT20220410054469N1Shahid Beheshti University of Medical Sciences216
进行中（未招募）
1 期
A randomised trial to compare ASPIRIN versus HYDROXYUREA/ASPIRIN in 'intermediate risk' primary thrombocythaemia and ASPIRIN only with observation in 'Low risk' primary thrombocythaemia. - PT1Intermediate risk and low risk primary thrombocythaemia.MedDRA version: 8.1Level: PTClassification code 10036735Term: Primary thrombocytopeniaEUCTR2004-000245-38-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,459
进行中（未招募）
1 期
A Clinical Trial of Low Dose Aspirin versus Placebo in High-Risk Individuals of Lung Cancer.ung cancer increased risk in current or former heavy smokers, with CT SCAN screen detected subsolid lung nodules (Cosmos Project)MedDRA version: 17.0Level: PTClassification code 10025065Term: Lung carcinoma cell type unspecified recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004862-32-ITIstituto Europeo Oncologia128